The Latest in Arrhythmias & EP

Approaching ventricular arrhythmias in a structurally normal heart

January 24, 2014

Arrhythmias & EP

FDA panel rejects rivaroxaban again for acute coronary syndrome

January 17, 2014

CRT shown highly cost effective in mild heart failure

January 16, 2014

Postop atrial fib has two peaks

January 16, 2014

Low event rates with real-world use of rivaroxaban in NOAC

January 15, 2014

Arrhythmias & EP

Ten-year outcomes for ablation in atrial fibrillation impressive

January 6, 2014

Genotyping adds little to optimized warfarin dosing

January 3, 2014

Novel Watchman antistroke device backed as warfarin equivalent

December 12, 2013

Advanced pacing slows AF progression in bradycardia

November 22, 2013

Substrate ablation shows no advantage for A fib

November 20, 2013

Anticoagulant edoxaban comparable with warfarin in atrial fib

November 19, 2013

Arrhythmias & EP

Atrial fib linked to incident myocardial infarction

November 4, 2013

On heart failure and beta-blocker dosages

October 24, 2013

Advisers support FDA approval of wireless HF monitoring device

October 10, 2013

FDA panel narrowly backs expanding CRT devices’ indications

October 9, 2013